{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 452164662
| IUPAC_name = ''N''-[(2''H''-1,3-benzodioxol-4-yl)methyl]-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine
| image = 25I-NBMD.svg
| width = 200

<!--Clinical data-->
| legal_UK = Class A
| tradename =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 919797-25-4
| PubChem = 57507899
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 26234932
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = R99110126K 
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C18H20INO4/c1-21-16-9-14(19)17(22-2)8-12(16)6-7-20-10-13-4-3-5-15-18(13)24-11-23-15/h3-5,8-9,20H,6-7,10-11H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = NJNMIPDEUMTYNV-UHFFFAOYSA-N

<!--Chemical data-->
| C=18 | H=20 | I=1 | N=1 | O=4
| molecular_weight = 441.259 g/mol
| smiles = c13OCOc3cccc1CNCCc(c(OC)cc2I)cc2OC
}}

'''25I-NBMD''' ('''NBMD-2C-I''', '''Cimbi-29''') is a derivative of the [[phenethylamine]] [[Psychedelic drug|hallucinogen]] [[2C-I]], discovered in 2006 by a team at [[Purdue University]] led by [[David E. Nichols|David Nichols]]. It acts as a potent [[partial agonist]] for the [[5HT2A receptor|5HT<sub>2A</sub>]] [[Receptor (biochemistry)|receptor]] with a [[Dissociation constant|Ki]] of 0.049nM at the human 5HT<sub>2A</sub> receptor.<ref>{{cite journal | last1 = Braden | first1 = MR | last2 = Parrish | first2 = JC | last3 = Naylor | first3 = JC | last4 = Nichols | first4 = DE | title = Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists | journal = Molecular Pharmacology | volume = 70 | issue = 6 | pages = 1956–64 | year = 2006 | pmid = 17000863 | doi = 10.1124/mol.106.028720 }}</ref><ref>[http://proquest.umi.com/pqdlink?Ver=1&Exp=01-23-2014&FMT=7&DID=1417800971&RQT=309&attempt=1&cfc=1 Michael Robert Braden PhD. Towards a biophysical understanding of hallucinogen action. Purdue University 2007.]</ref><ref>{{Cite journal |doi= 10.1007/s00259-010-1686-8 |last= Ettrup |first= A. | last2= Hansen | first2= M. |last3= Santini | first3= M. A. |last4= Paine | first4= J. |last5= Gillings | first5= N. |last6= Palner | first6= M. |last7= Lehel | first7= S. |last8= Herth | first8= M. M. |last9= Madsen | first9= J. | first10= J. | last10= Kristensen |displayauthors=9 | first11= M. | last11 = Begtrup | first12= G. M. | last12 = Knudsen | title = Radiosynthesis and ''in vivo'' evaluation of a series of substituted <sup>11</sup>C-phenethylamines as 5-HT<sub>2A</sub> agonist PET tracers |journal= European Journal of Nuclear Medicine and Molecular Imaging |volume= 38 |issue= 4 |pages= 681–93 |year= 2010 |pmid= 21174090 }}
</ref> The corresponding 4-bromo analogue 25B-NBMD has been used for molecular dynamics studies on the shape of the 5-HT<sub>2A</sub> receptor.<ref name="pmid21261291">{{cite journal |vauthors=Isberg V, Balle T, Sander T, Jørgensen FS, Gloriam DE |title=G protein- and agonist-bound serotonin 5-HT2A receptor model activated by steered molecular dynamics simulations |journal=Journal of Chemical Information and Modeling |volume=51 |issue=2 |pages=315–25 |date=February 2011 |pmid=21261291 |doi=10.1021/ci100402f |url=}}</ref>

==Legality==

===Sweden===
[[Riksdag|The Riksdag]] added 25I-NBMD to [[:sv:Narkotikastrafflagen|Narcotic Drugs Punishments Act]] under ''swedish schedule I'' (''"substances, plant materials and fungi which normally do not have medical use"'') as of January 16, 2015, published by [[Medical Products Agency (Sweden)|Medical Products Agency (MPA)]] in regulation ''LVFS 2014:11'' listed as '''25I-NBMD''', and '''2-(4-jodo-2,5-dimetoxifenyl)-N-[(2,3-metylendioxifenyl)metyl]etanamin'''.<ref>https://lakemedelsverket.se/upload/lvfs/LVFS_2014_11.pdf</ref>

===United Kingdom===
{{N-benzylphenethylamine-Legality-United Kingdom}}

==Analogues and derivatives==
{{2C-I analogues and derivatives}}

==References==
{{reflist}}

{{Hallucinogens}}
{{Serotonin receptor modulators}}
{{Phenethylamines}}

[[Category:25-NB (psychedelics)]]
[[Category:Benzodioxoles]]
[[Category:Designer drugs]]
[[Category:Iodoarenes]]
[[Category:Phenol ethers]]
[[Category:Serotonin receptor agonists]]

{{hallucinogen-stub}}